Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Chkioua, Latifa ^a,b   Khedhiri, Souhir ^a,b   Ferchichi, Salima ^a,b   Tcheng, Rémy ^c   Chahed, Henda ^a,b   Froissart, Roseline ^c   Vianey Saban, Christine ^c   Laradi, Sandrine ^a,b   Miled, Abdelhedi ^a,b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c Center of biology and pathology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IDURONATE 2 SULFATASE;

ARTICLE; CASE REPORT; CHILD; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; HUNTER SYNDROME; INFANT; MALE; MUTATION; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IDURONATE SULFATASE; INFANT; MALE; MUCOPOLYSACCHARIDOSIS II; MUTATION; POLYMORPHISM, GENETIC;

EID: 79956214174     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-42     Document Type: Article

References (33)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. The metabolic basis of inherited disease 1989, 1565-1588. McGraw-Hill, New York, Scriver CR, Beaudet AL, Sly WS, Valle D, 6.
2. Elizabeth JR, McKinnis BA, Sulzbacher Stephen P, Joe C, Rutledge MD, Jean Sanders MD, Scott C, Ronald MD. Bone marrow transplantation in Hunter syndrome. Pediatrics 1990, 85:1092-102.
3. Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Pñdiatr Suppl 2002, 439:98-99.
4. Wilson PJ, Suthers GK, Callen DF, Baker E, Nelson PV, Cooper A, Wraith JE, Sutherland GR, Morris CP, Hopwood JJ. Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet 1991, 86:505-508.
5. DiNatale P, Ronsisvalle L. Identification and partial characterization of two enzyme forms of iduronate sulfatase from human placenta. Biochim Biophys Acta 1981, 661:106-111.
6. Bielicki J, Freeman C, Clements PR, Hopwood JJ. Human liver iduronate-2-sulphatase: purification, characterization and catalytic properties. Biochem J 1990, 271:75-86. 1149515, 2222422.
7. Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Nat Acad Sci 1990, 87:8531-8535. 10.1073/pnas.87.21.8531, 54990, 2122463.
8. Ricci V, Filocamo M, Regis S, Corsolini F, Stroppiano M, Di Duca M, Gatti R. Expression studies of two novel in cis-mutations identified in an intermediate case of Hunter syndrome. Am J Med Genet 2003, 120A:84-87. 10.1002/ajmg.a.10215, 12794697.
9. Bondeson ML, Dahl N, Malmgren H, Kleijer WJ, Tonnesen T, Carlberg BM, Pettersson U. Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Molec Genet 1995, 4:615-621. 10.1093/hmg/4.4.615, 7633410.
10. McKusick VA. The Mucopolysaccharidoses. Heritable Disorders of Connective Tissue 1972, 556-574. St. Louis: C. V. Mosby, 4.
11. Chaabouni M, Ben Slimen M, Boudawara M, Ben Amar H, Mahfoudh A, Ayadi F, Ben Halima N, Hachicha M, Karaay A, Triki A. Mucopolysaccharidoses in children. Experience of a general pediatric service 11 cases. Tunis Med 2001, 79:222-300.
12. Voznyi YV, Keulemans JL, van Diggelen OP. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis 2001, 24:675-80. 10.1023/A:1012763026526, 11768586.
13. Mirella F, Gloria B, Fabio C, Raffaella M, Roberto C, Rosanna G. Molecular Analysis of 40 Italian Patients With Mucopolysaccharidosis Type II: New Mutations in the Iduronate-2-sulfatase (IDS) Gene. Hum Mutat 2002,
14. Applegarth D, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000, 105:1-6. 10.1542/peds.105.1.1, 10617696.
15. Machill G, Barbujani G, Danieli GA, Hermann FH. Segregation and sporadic cases in families with Hunter_s syndrome. J Med Genet 1991, 28:398-40. 10.1136/jmg.28.6.398, 1016905, 1908009.
16. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999, 281:249-254. 10.1001/jama.281.3.249, 9918480.
17. Nelson J. Incidence of mucopolysaccharidoses in Northern Ireland. Hum Genet 1997, 101:355-358. 10.1007/s004390050641, 9439667.
18. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet 2003, 123A:310-31. 10.1002/ajmg.a.20314, 14608657.
19. Poorthuis BJHM, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, Niezen-Koning KE, van Diggelen OP. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999, 105:151-15.
20. Young ID, Harper PS. Incidence of Hunter's syndrome. Hum Genet 1982, 60:391-392. 10.1007/BF00569230, 6809596.
21. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, Chao MC, Chiu PC, Lin SJ, Tsai LP, Hwu WL, Lin JL. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Am J Med Genet 2009, 149A:960-964. 10.1002/ajmg.a.32781, 19396827.
22. Lin SP, Chang JH, Lee-Chen GJ, Lin DS, Lin HY, Chuang CK. Detection of hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: Biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers. Clinica Chimica Acta 2006, 29-34.
23. Laradi S, Monastiri K, Ferchichi S, Nabli N, Aouini Rea P, Ben Limam H, Miled A. Clinical, biological and molecular study of mucopolysaccharides in central and southTunisia. Ann Biol Clin 2001, 59:100-4.
24. Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Ben Chehida A, Chemli J, Monastiri K, Chaabouni M, Sanhagi H, Zouari B, Kaabachi N, Ben Dridi MF. Incidence of mucopolysaccharidoses in Tunisia. Tunis Med 2009, 87:782-785.
25. Broadhead DM, Kirk JM, Burt AJ, Gupta V, Ellis PM, Besley GT. Full expression of Hunter's disease in a female with an X-chromosome deletion leading to non-random inactivation. Clin Genet 1986, 30:392-398.
26. Clarke JTR, Pearce RD, Greer WL, Strasberg P, Ray PN. Hunter disease (MPS, type II) in a karyotypically normal girl associated with selective X-chromosome inactivation. Am J Hum Genet 1990, 47.
27. Balzano N, Villani GR, Grosso M, Izzo P, Di Natale P. Detection of four novel mutations in the iduronate-2-sulfatase gene. Mutations in brief. Hum Mutat 1998, 11:333.
28. Chi HK, Hye ZH, Seng MS, Kyung HP, Eun KK, Kwang BM, Jeong HY, Cheol KH, Dong KJ. Mutational Spectrum of the Iduronate 2 Sulfatase Gene in 25 Unrelated Korean Hunter Syndrome Patients: Identification of 13 Novel Mutations. Hum Mutat 2003, 599.
29. Villani GRD, Daniele A, Balzano N. Expression of five iduronate-2-sulfatase site-directed mutations. Biochimica et Biophysica Acta 2000, 1501:71-8.
30. Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, Gal A. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulfatase gene. Hum Mutat 1993, 2:435-442. 10.1002/humu.1380020603, 8111411.
31. Flomen RH, Green PM, Bentley DR, Giannelli F, Green EP. Detection of point mutations and a gross deletion in six Hunter syndrome patients. Genomics 1992, 13:543-550. 10.1016/0888-7543(92)90123-A, 1639384.
32. Chkioua L, Khedhiri S, Kassab A, Bibi A, Ferchichi S, Froissart R, Vianey-Saban C, Laradi S, Miled A. Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms. Diagn Pathol 2011, 6:39. 10.1186/1746-1596-6-39, 21521498.
33. Khedhiri S, Chkioua L, Ferchichi S, Miled A, Laradi S. Polymorphisms in Tunisian patients with N-acetylgalactosamine-6-sulfate sulfatase gene deficiency: Implication in Morquio A disease. Diagn Pathol 2011, 6:11. 10.1186/1746-1596-6-11, 3034659, 21251309.